Clinical Trial Update: A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 [Phase 1]

View source ↗

Summary

A Phase 1b study evaluating safety, tolerability, pharmacokinetics, and exploratory efficacy of intravitreal OLN324 in diabetic macular edema and neovascular ag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• OLN324

Snippet

Sponsor: Ollin Biosciences, Inc. | Conditions: Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration | Phase 1 | Status: COMPLETED